期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Gut microbiota-mediated metabolism of Panax notoginseng saponins and its role in pharmacokinetics and pharmacodynamics
1
作者 Yu-Ying Zheng Wei-Wei Su +2 位作者 Yu-Ling Liu Wei-Jian Zhang Xuan Zeng 《Traditional Medicine Research》 2024年第12期41-50,共10页
Panax notoginseng saponins(PNS)are a class of effective ingredients in Notoginseng Radix et Rhizoma,a well-known herbal medicine called San-Qi in Chinese.After oral administration,PNS inevitably interacts with gut mic... Panax notoginseng saponins(PNS)are a class of effective ingredients in Notoginseng Radix et Rhizoma,a well-known herbal medicine called San-Qi in Chinese.After oral administration,PNS inevitably interacts with gut microbiota,and thus affect the pharmacokinetic profiles and pharmacological effects.To date,studies concering gut microbiota-mediated metabolism of PNS have not been reviewed systematically.Herein,we outline the metabolic profiles of Panax notoginseng saponins mediated by gut microbiota,as well as its role in the pharmacokinetics and pharmacodynamics on the basis of reported data.The metabolic pathways of primary saponins are proposed,and step-by-step deglycosylation is found to be the primary degradation pathways of PNS mediated by gut microbiota.Specific microorganisms and enzymes involved in the metabolic processes were summarized.Gut microbiota is deeply involved in the metabolism of PNS,affects the pharmacokinetic profiles,and produces a series of active metabolites.These metabolites were documented to play an essential role in the efficacy of the parent compounds.Future studies should focus on strengthening the real-world evidence,defining the interaction between gut microbiota and PNS,and developing the strategy for modulating gut microbiota to enhance the bioavailability and efficacy of PNS.These information would be useful for further research and clinical application of PNS. 展开更多
关键词 Panax notoginseng saponins gut microbiota METABOLISM PHARMACOKINETICS PHARMACODYNAMICS
下载PDF
粤东地区1430例新生儿遗传性耳聋基因筛查结果分析 被引量:15
2
作者 方炳雄 蔡勉珊 +4 位作者 张俊贤 翁文婕 冯心乐 阮杰 黄娟 《广东医科大学学报》 2019年第1期12-15,共4页
目的分析粤东地区遗传性耳聋基因突变类型及突变携带率,为早期发现新生儿耳聋和早期干预提供参考。方法运用PCR结合导流杂交法(耳聋易感基因检测试剂盒)检测粤东地区1 430例新生儿4个遗传性耳聋基因(GJB2、SLC26A4、线粒体DNA、GJB3基因... 目的分析粤东地区遗传性耳聋基因突变类型及突变携带率,为早期发现新生儿耳聋和早期干预提供参考。方法运用PCR结合导流杂交法(耳聋易感基因检测试剂盒)检测粤东地区1 430例新生儿4个遗传性耳聋基因(GJB2、SLC26A4、线粒体DNA、GJB3基因)的13个常见突变位点。查阅广东地区发表的耳聋基因筛查相关文献,分析本地区耳聋基因的流行概况。结果 1 430例新生儿中,检出耳聋基因突变的55例,总阳性率为3.85%,其中GJB2、SLC26A4、GJB3和线粒体DNA耳聋基因的突变率依次为1.61%、1.33%、0.42%和0.28%。检出最多是GJB2 235del和SLC26A4 IVS7-2A>G位点的突变,单基因检出率分别为1.40%和1.05%。双基因突变检出3例,其中GJB2 235delC/SLC26A4 IVS7-2复合杂合突变2例,GJB2 176del16/SLC26A4 IVS7-2复合杂合突变1例;根据文献报道显示,广东其他地区4个耳聋基因的总突变率为3.31%~4.47%,最常见的突变位点是GJB2 235delC和SLC26A4 IVS7-2A>G,其次是GJB2 299delAT和线粒体DNA 1555A>G。结论粤东地区新生儿耳聋基因突变情况与广东其他地区的基本一致,主要的突变类型为GJB2 235delC和SLC26A4 IVS7-2A>G。 展开更多
关键词 耳聋基因 新生儿筛查 粤东地区
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部